Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
SeeInMe develops a digital health platform designed to enhance person-centered coordinated care for care recipients.
The leading digital therapeutic and community for Alzheimer’s and cognitive health
This company is provides cutting edge analysis of brain images to enable disease diagnosis.
Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Cleveland Alzheimer's Disease Research Center is the multi-institutional Alzheimer research center.
Amptify is an ecosystem of hearing health built to improve the provider and patient experience through comprehensive tech-enhanced care.
Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
Lumia builds wearable that tracks blood flow to help people understand their bodies, improve well-being, and make proactive health choices.
Evon Medics, LLC is focused on developing and delivering breakthrough therapeutics and devices to address brain-related conditions.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Blue Marble Health is telehealth and remote therapeutic monitoring platform for aging and chronic disease management.
Onward provides SAAS + Rides for older adults & people with disabilities, ensuring access to healthcare, social, & daily needs.
Illuminant Surgical is building a new way of seeing inside the human body.
Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Tulane University Brain Institute focus on understanding why estrogen therapy helps protect some women from age-related brain problems.
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
Homecare Hub is an platform which has developed a marketplace that helps patients to find the high quality home care providers.
Praetego is a pharmaceutical company focused on addressing serious diabetic complications.
Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.
National Institute on Aging has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute on Aging's top investment sectors include Health Care, Biotechnology, Medical, Health Diagnostics, Therapeutics. The firm invests across 40 different industry categories.
Among tracked funding rounds, Alzheon received $100.0M in a Series E round. National Institute on Aging's total known invested capital is $166.4M.
National Institute on Aging's average investment size is $4.2M across its portfolio of 65 companies.
Recent National Institute on Aging portfolio additions include Diadem, T3D Therapeutics, BetterAge, ADvantage Therapeutics, SeeInMe. These companies were founded in 2020 or later.